Cargando…

Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System on Platelets in Systemic Lupus Erythematosus

Anti-phospholipid (aPL) antibodies are important contributors to development of thrombosis in patients with the autoimmune rheumatic disease systemic lupus erythematosus (SLE). The underlying mechanism of aPL antibody-mediated thrombosis is not fully understood but existing data suggest that platele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lood, Christian, Tydén, Helena, Gullstrand, Birgitta, Sturfelt, Gunnar, Jönsen, Andreas, Truedsson, Lennart, Bengtsson, Anders A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055750/ https://www.ncbi.nlm.nih.gov/pubmed/24922069 http://dx.doi.org/10.1371/journal.pone.0099386

Ejemplares similares

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2017)

Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
por: Linge, Carl Petrus, et al.
Publicado: (2022)

The assessment of serum-mediated phagocytosis of necrotic material by polymorphonuclear leukocytes to diagnose and predict the clinical features of systemic lupus erythematosus: an observational longitudinal study
por: Compagno, Michele, et al.
Publicado: (2016)

Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus
por: Lood, Christian, et al.
Publicado: (2011)

Low Intra-Individual Variation in Mean Platelet Volume Over Time in Systemic Lupus Erythematosus
por: Wirestam, Lina, et al.
Publicado: (2021)

Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus
por: Tydén, Helena, et al.
Publicado: (2019)

Analysis of HLA DR, HLA DQ, C4A, FcγRIIa, FcγRIIIa, MBL, and IL-1Ra allelic variants in Caucasian systemic lupus erythematosus patients suggests an effect of the combined FcγRIIa R/R and IL-1Ra 2/2 genotypes on disease susceptibility
por: Jönsen, Andreas, et al.
Publicado: (2004)

Type I Interferon-Mediated Skewing of the Serotonin Synthesis Is Associated with Severe Disease in Systemic Lupus Erythematosus
por: Lood, Christian, et al.
Publicado: (2015)

Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
por: Ekman, Carl, et al.
Publicado: (2011)

Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus
por: Jönsen, Andreas, et al.
Publicado: (2011)

Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
por: Bengtsson, Anders A., et al.
Publicado: (2020)

Degradation of neutrophil extracellular traps co-varies with disease activity in patients with systemic lupus erythematosus
por: Leffler, Jonatan, et al.
Publicado: (2013)

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
por: Svenungsson, Elisabet, et al.
Publicado: (2020)

Plasma C4d as marker for lupus nephritis in systemic lupus erythematosus
por: Martin, Myriam, et al.
Publicado: (2017)

Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
por: Wu, Jun, et al.
Publicado: (2011)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
por: Vils, Signe Risbøl, et al.
Publicado: (2023)

Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
por: Sjöwall, Christopher, et al.
Publicado: (2004)

Plasma and cerebrospinal fluid neurofilament light concentrations reflect neuronal damage in systemic lupus Erythematosus
por: Zervides, Kristoffer A., et al.
Publicado: (2022)

Neutrophil and lymphocyte counts are associated with different immunopathological mechanisms in systemic lupus erythematosus
por: Han, Bobby Kwanghoon, et al.
Publicado: (2020)

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren’s Syndrome and Systemic Sclerosis
por: Bengtsson, Anders A., et al.
Publicado: (2016)

Serum S100A8/A9 concentrations are associated with neuropsychiatric involvement in systemic lupus erythematosus: a cross-sectional study
por: Zervides, Kristoffer A., et al.
Publicado: (2022)

Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
por: Enocsson, Helena, et al.
Publicado: (2021)

Low production of reactive oxygen species in granulocytes is associated with organ damage in systemic lupus erythematosus
por: Bengtsson, Anders A, et al.
Publicado: (2014)

Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays
por: Carlsson, Anders, et al.
Publicado: (2011)

A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources
por: Leffler, Jonatan, et al.
Publicado: (2015)

A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
por: Sigurdsson, Snaevar, et al.
Publicado: (2008)

Complement and systemic lupus erythematosus
por: Walport, Mark J
Publicado: (2002)

Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus
por: Bäck, Jennie, et al.
Publicado: (2013)

Platelet distribution width as a novel indicator of disease activity in systemic lupus erythematosus
por: Chen, Sun-Yi, et al.
Publicado: (2018)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
por: Cornwell, MacIntosh Grant, et al.
Publicado: (2021)

Assessment of Mean Platelet Volume in Patients with Systemic Lupus Erythematosus
por: Hartmann, Lisandra Torres, et al.
Publicado: (2018)

Platelet activation leads to activation and propagation of the complement system
por: del Conde, Ian, et al.
Publicado: (2005)

No evidence for a putative involvement of platelet-activating factor in systemic lupus erythematosus without active nephritis.
por: Denizot, Yves, et al.
Publicado: (2003)

C-Reactive Protein Levels in Systemic Lupus Erythematosus Are Modulated by the Interferon Gene Signature and CRP Gene Polymorphism rs1205
por: Enocsson, Helena, et al.
Publicado: (2021)

The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System
por: Eriksson, Oskar, et al.
Publicado: (2019)

Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's Syndrome
por: Lundtoft, Christian, et al.
Publicado: (2022)

Sex differences in clinical presentation of systemic lupus erythematosus
por: Ramírez Sepúlveda, Jorge I., et al.
Publicado: (2019)

Coagulation cascade and complement system in systemic lupus erythematosus
por: Liang, Yan, et al.
Publicado: (2017)

Complement as a Biomarker for Systemic Lupus Erythematosus
por: Ayano, Masahiro, et al.
Publicado: (2023)

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
por: Ramsey‐Goldman, Rosalind, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_502r42fg1iqccc5c0v0lfdg5au